The effect of six weeks of combined training on the resting plasma level of Pentraxin-3 and Serum amyloid A in men with type-2 diabetes

Document Type : original article

Authors

Department of Exercise Physiology , Faculty of Physical Education and Sport Sciences , University of Tehran, Tehran , Iran

Abstract

Background and Purpose: The aim of this study was to investigate the effect of combined exercise on resting levels of pentraxin3 (PTX3) and serum amyloid A (SAA) in the plasma of men with type-2 diabetes.
Materials and Methods: Twenty oen-athlete men with type-2 diabetes were randomly divided into control and training groups. Combined training was performed for six weeks. Training including 25-35 minutes of aerobic exercise with an intensity of 55-75% of maximum heart rate and five resistance movements involving large muscles in the upper and lower body Includes five movements: chest press, army press, squat, dead lift, dumbbell rowing with an intensity of 55-75% of a maximum repetition with a frequency of three times a week with the periorizing of resistance training on aerobic training . The intensity of aerobic exercise was measured with heart rate monitor and the intensity of resistance training was measured every two weeks with a maximum repetition test. For data analysis, dependent and independent t-test was used at the significant level of P ≤ 0.05.
Results: Examining the results of the study, it was found that the training contract reduced the SAA index (16.7%) and significantly changed it in the training group compared to the control group (P = 0.047 . However, there was no effect on resting SAA in the control group and a 2.2% increase in PTX3 in the training group was not significant (P = 0.474).
Conclusion: According to the results of the study and a significant decrease in inflammatory factor SAA and increase in PTX3, it can be concluded that six weeks of combined training affects the levels of these factors in men with type-2 diabetes and can probably reduce inflammation in these patients.

Keywords

References

  1. Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. The Lancet. 2017.
  2. Getz GS, Krishack PA, Reardon CA. Serum amyloid A and atherosclerosis. Current opinion in lipidology. 2016;27(5):531-5.
  3. Slusher AL, Huang C-J, Acevedo EO. The Potential Role of Aerobic Exercise-Induced Pentraxin 3 on Obesity-Related Inflammation and Metabolic Dysregulation. Mediators of inflammation. 2017;2017.
  4. Breviario F, d'Aniello EM, Golay J, Peri G, Bottazzi B, Bairoch A, et al. Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. Journal of Biological Chemistry. 1992;267(31):22190-7.
  5. Altmeyer A, Klampfer L, Goodman AR, Vilcek J. Promoter structure and transcriptional activation of the murine TSG-14 gene encoding a tumor necrosis factor/interleukin-1-inducible pentraxin protein. Journal of Biological Chemistry. 1995;270(43):25584-90.
  6. Yamada T. Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness. Clinical chemistry and laboratory medicine. 1999;37(4):381-8.
  7. Cocco E, Bellone S, El‐Sahwi K, Cargnelutti M, Buza N, Tavassoli FA, et al. Serum amyloid A. Cancer. 2010;116(4):843-51.
  8. Savchenko A, Imamura M, Ohashi R, Jiang S, Kawasaki T, Hasegawa G, et al. Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions. The Journal of pathology. 2008;215(1):48-55.
  9. Lee R, Shin M-H, Kim H-N, Lee Y-H, Choi S-W, Ahn H-R, et al. Relationship between plasma pentraxin 3 level and risk of chronic kidney disease in the Korean elderly: the Dong-gu study. International Urology and Nephrology. 2017;49(11):2027-33.
  10. Chu SH, Park J-H, Lee MK, Jekal Y, Ahn KY, Chung JY, et al. The association between pentraxin 3 and insulin resistance in obese children at baseline and after physical activity intervention. Clinica Chimica Acta. 2012;413(19):1430-7.
  11. Mahmoudi A, Siauhkouhian M, Iranparvar M, Anari H, Seifi F. Plasma Changes of Chemerin and Pentraxin-3 Following Eight Weeks of Endurance Exercise in Men with Non-Alcoholic Fatty Liver Disease. Journal of Ardabil University of Medical Sciences. 2018;17(4):476-86. (In Persian).
  12. Hua S, Song C, Geczy CL, Freedman SB, Witting PK. A role for acute-phase serum amyloid A and high-density lipoprotein in oxidative stress, endothelial dysfunction and atherosclerosis. Redox Report. 2009;14(5):187-96.
  13. Anderberg RJ, Meek RL, Hudkins KL, Cooney SK, Alpers CE, Leboeuf RC, et al. Serum amyloid A and inflammation in diabetic kidney disease and podocytes. Laboratory Investigation. 2015;95(3):250.
  14. Nakajima T, Kurano M, Hasegawa T, Takano H, Iida H, Yasuda T, et al. Pentraxin3 and high-sensitive C-reactive protein are independent inflammatory markers released during high-intensity exercise. European journal of applied physiology. 2010;110(5):905-13.
  15. Miyaki A, Maeda S, Choi Y, Akazawa N, Tanabe Y, Ajisaka R. Habitual aerobic exercise increases plasma pentraxin 3 levels in middle-aged and elderly women. Applied physiology, nutrition, and metabolism. 2012;37(5):907-11.
  16. Serra MC, Ryan AS, Ortmeyer HK, Addison O, Goldberg AP. Resistance training reduces inflammation and fatigue and improves physical function in older breast cancer survivors. Menopause. 2018;25(2):211-6.
  17. Ryan AS, Ge S, Blumenthal JB, Serra MC, Prior SJ, Goldberg AP. Aerobic exercise and weight loss reduce vascular markers of inflammation and improve insulin sensitivity in obese women. Journal of the American Geriatrics Society. 2014;62(4):607-14.
  18. Pazoki AH, Choobineh S, Akbarnejad A. The Effect of Six Weeks Combined Training on Plasma Levels ofChemerin, Serum Amyloid A and C-reactive Proteine and Plasma Lipid in Obese Male. Arak Medical University Journal. 2016;19(1). (In Persian).
  19. Ihalainen JK, Schumann M, Eklund D, Hämäläinen M, Moilanen E, Paulsen G, et al. Combined aerobic and resistance training decreases inflammation markers in healthy men. Scandinavian journal of medicine & science in sports. 2018;28(1):40-7.
  20. Liu Y, Liu S-x, Cai Y, Xie K-l, Zhang W-l, Zheng F. Effects of combined aerobic and resistance training on the glycolipid metabolism and inflammation levels in type 2 diabetes mellitus. Journal of physical therapy science. 2015;27(7):2365-71.
  21. Takhshid MA, Ghasemi M. Methods for assessing insulin sensitivity and resistance. Laboratory & Diagnosis. 2014;6(23):8-13.
  22. Zhao Y, He X, Shi X, Huang C, Liu J, Zhou S, et al. Association between serum amyloid A and obesity: a meta-analysis and systematic review. Inflammation Research. 2010;59(5):323-34.
  23. Winters-Stone KM, Wood LJ, Stoyles S, Dieckmann NF. The effects of resistance exercise on biomarkers of breast cancer prognosis: a pooled analysis of three randomized trials. Cancer Epidemiology and Prevention Biomarkers. 2018;27(2):146-53.
  24. Yang R-Z, Lee M-J, Hu H, Pollin TI, Ryan AS, Nicklas BJ, et al. Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS medicine. 2006;3(6):e287.
  25. Griffiths K, Pazderska A, Ahmed M, McGowan A, Maxwell AP, McEneny J, et al. Type 2 diabetes in young females results in increased serum amyloid A and changes to features of high density lipoproteins in both HDL2 and HDL3. Journal of diabetes research. 2017;2017.
  26. Safarzade A, Basiri A. Changes in plasma acute phase proteins (SAA and CRP) levels following 8 weeks of circuit resistance training in obese men. Metabolism and Exercise. 2015;4(2):109-19.( In Persian).
  27. Campbell PT, Campbell KL, Wener MH, Wood B, Potter JD, McTIERNAN A, et al. A yearlong exercise intervention decreases CRP among obese postmenopausal women. Medicine and science in sports and exercise. 2009;41(8).
  28. Koloverou E, Tambalis K, Panagiotakos DB, Georgousopoulou E, Chrysohoou C, Skoumas I, et al. Moderate physical activity reduces 10-year diabetes incidence: the mediating role of oxidative stress biomarkers. International journal of public health. 2018;63(2):297-305.
  29. Weiss EP, Reeds DN, Ezekiel UR, Albert SG, Villareal DT. Circulating cytokines as determinants of weight loss-induced improvements in insulin sensitivity. Endocrine. 2017;55(1):153-64.
  30. Miyaki A, Choi Y, Maeda S. Pentraxin 3 production in the adipose tissue and the skeletal muscle in diabetic-obese mice. The American journal of the medical sciences. 2014;347(3):228-33.
  31. Tunc-Ata M, Turgut G, Mergen-Dalyanoglu M, Turgut S. Examination of levels pentraxin-3, interleukin-6, and C-reactive protein in rat model acute and chronic exercise. Journal of exercise rehabilitation. 2017;13(3):279.
  32. Zempo-Miyaki A, Kumagai H, Yoshikawa T, Myoenzono K, So R, Otsuki T, et al. Pentraxin 3 increases in adult overweight and obese men after weight loss by dietary modification with exercise training. Applied Physiology, Nutrition, and Metabolism. 2018;44(2):111-7.

Files

History

  • Receive Date: 13 May 2020
  • Revise Date: 14 November 2021
  • Accept Date: 26 November 2021
  • First Publish Date: 10 August 2022
  • Publish Date: 23 August 2022

Share

How to cite

Statistics